|
|
| (16 intermediate revisions by 7 users not shown) |
| Line 1: |
Line 1: |
| '''For patient information on Neurosyphilis, click [[Neurosyphilis (patient information)|here]]'''
| | __NOTOC__ |
| | | <br /> |
| {{DiseaseDisorder infobox | | | {{DiseaseDisorder infobox | |
| Name = Syphilis | | | Name = Syphilis | |
| Image = Treponema pallidum.jpg | | | Image = Treponema pallidum.jpg | |
| Caption = Image of spiral-shaped organisms responsible for causing syphilis | | | Caption = Image of spiral-shaped organisms responsible for causing syphilis | |
| ICD10 = {{ICD10|A|50||a|50}}-{{ICD10|A|53||a|50}} |
| |
| ICD9 = {{ICD9|090}}-{{ICD9|097}} |
| |
| ICDO = |
| |
| OMIM = |
| |
| DiseasesDB = |
| |
| MedlinePlus = 001327 |
| |
| eMedicineSubj =|
| |
| eMedicineTopic = |
| |
| eMedicine_mult =
| |
| }} | | }} |
| {{Syphilis}} | | {{Neurosyphilis}} |
| {{CMG}}; {{AOEIC}} {{LG}} | | {{CMG}}; {{AE}}{{MMJ}} |
| | |
| | ==[[Neurosyphilis overview|Overview]]== |
| | |
| | ==[[Neurosyphilis pathophysiology|Pathophysiology]]== |
| | |
| | ==[[Neurosyphilis causes|Causes]]== |
|
| |
|
| ==Neurosyphilis Among HIV-Infected Persons== | | ==[[Neurosyphilis differential diagnosis|Differentiating Neurosyphilis from other Diseases]]== |
| ====Treatment====
| |
| [[HIV]]-infected patients with [[neurosyphilis]] should be treated according to the recommendations for HIV-negative patients with neurosyphilis. | |
|
| |
|
| ====Special considerations==== | | ==[[Neurosyphilis risk factors|Risk Factors]]== |
| *HIV-infected, [[Syphilis medical therapy#Pencillin allergy|penicillin-allergic]] patients who have [[neurosyphilis]] should be managed according to the recommendations for penicillin-allergic, HIV-negative patients with neurosyphilis.
| |
|
| |
|
| *Several small observational studies conducted in HIV-infected patients with neurosyphilis suggest that [[ceftriaxone]] 1-2 g IV daily for 10-14 days might be effective as an alternate agent.<ref name="pmid1442850">Dowell ME, Ross PG, Musher DM, Cate TR, Baughn RE (1992) [http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=1442850 Response of latent syphilis or neurosyphilis to ceftriaxone therapy in persons infected with human immunodeficiency virus.] ''Am J Med'' 93 (5):481-8. PMID: [http://pubmed.gov/1442850 1442850]</ref><ref name="pmid15117503">Smith NH, Musher DM, Huang DB, Rodriguez PS, Dowell ME, Ace W et al. (2004) [http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=15117503 Response of HIV-infected patients with asymptomatic syphilis to intensive intramuscular therapy with ceftriaxone or procaine penicillin.] ''Int J STD AIDS'' 15 (5):328-32. [http://dx.doi.org/10.1258/095646204323012823 DOI:10.1258/095646204323012823] PMID: [http://pubmed.gov/15117503 15117503]</ref><ref name="pmid18532887">Ghanem KG, Moore RD, Rompalo AM, Erbelding EJ, Zenilman JM, Gebo KA (2008) [http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=18532887 Antiretroviral therapy is associated with reduced serologic failure rates for syphilis among HIV-infected patients.] ''Clin Infect Dis'' 47 (2):258-65. [http://dx.doi.org/10.1086/589295 DOI:10.1086/589295] PMID: [http://pubmed.gov/18532887 18532887]</ref>
| | ==[[Neurosyphilis natural history, complications and prognosis|Natural History, Complications and Prognosis]]== |
|
| |
|
| ====Follow-up==== | | ==Diagnosis== |
| *If [[Lumbar puncture#Diagnostics|CSF pleocytosis]] was present initially, a [[Syphilis laboratory tests#CSF analysis|CSF examination]] should be repeated every 6 months until the cell count is normal.
| |
|
| |
|
| *Follow-up CSF examinations also can be used to gauge response after therapy.
| | [[Neurosyphilis history and symptoms|History and Symptoms]] | [[Neurosyphilis physical examination|Physical Examination]] | [[Neurosyphilis laboratory findings|Laboratory Findings]] | [[Neurosyphilis MRI|MRI]] | [[Neurosyphilis other imaging findings|Other Imaging Findings]] | [[Neurosyphilis other diagnostic studies|Other Diagnostic Studies]] |
|
| |
|
| *Limited data suggest that changes in CSF parameters might occur more slowly in HIV-infected patients, especially those with more advanced immunosuppression.<ref name="pmid15034833">Marra CM, Maxwell CL, Tantalo L, Eaton M, Rompalo AM, Raines C et al. (2004) [http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=15034833 Normalization of cerebrospinal fluid abnormalities after neurosyphilis therapy: does HIV status matter?] ''Clin Infect Dis'' 38 (7):1001-6. [http://dx.doi.org/10.1086/382532 DOI:10.1086/382532] PMID: [http://pubmed.gov/15034833 15034833]</ref><ref name="pmid18525260">Ghanem KG, Moore RD, Rompalo AM, Erbelding EJ, Zenilman JM, Gebo KA (2008) [http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=18525260 Neurosyphilis in a clinical cohort of HIV-1-infected patients.] ''AIDS'' 22 (10):1145-51. [http://dx.doi.org/10.1097/QAD.0b013e32830184df DOI:10.1097/QAD.0b013e32830184df] PMID: [http://pubmed.gov/18525260 18525260]</ref>
| | ==Treatment== |
|
| |
|
| *If the cell count has not decreased after 6 months or if the CSF is not normal after 2 years, retreatment should be considered.
| | [[Neurosyphilis medical therapy|Medical Therapy]] | [[Neurosyphilis primary prevention|Primary Prevention]] | [[Neurosyphilis secondary prevention|Secondary Prevention]] | [[Neurosyphilis cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Neurosyphilis future or investigational therapies|Future or Investigational Therapies]] |
|
| |
|
| ==Related chapters== | | ==Case Studies== |
| | [[Neurosyphilis case study one|Case #1]] |
| | |
| | ==Related Chapters== |
| *[[Syphilis]] | | *[[Syphilis]] |
| *[[Congenital syphilis]] | | *[[Congenital syphilis]] |
|
| |
|
| ==Resources== | | ==External Links== |
| *[http://hivinsite.ucsf.edu/InSite?page=kb-05-01-04 UCSF HIV InSite Knowledge Base Chapter: Syphilis and HIV]
| |
| *[http://colman.net/eadv/index.html "A New Gold Standard For Syphilis?" Poster Presentation for European Academy of Dermatology and Venereology 2004 Spring Symposium]
| |
| *[http://www.stdhelp.org/about/syphilis.php Syphilis Pictures and Information]
| |
| *[http://medinfo.ufl.edu/other/histmed/clancy/ Kipkeepers, Pox and Gleet Vendors: A Rapid History of Syphilis]
| |
| *[http://www.poxhistory.com/ POX: Genius, Madness, and the Mysteries of Syphilis]
| |
| *[http://www.yourstdhelp.com/syphilis.html Syphilis Informational resource ]
| |
| *[http://www.pbs.org/wnet/secrets/case_syphilis/index.html Secrets of the Dead (PBS): The Syphilis Enigma]
| |
| *[http://www.cbc.ca/ideas/Aids Syphilis and AIDS: Lessons from history]
| |
| *[http://www.cdc.gov/std/Syphilis/STDFact-Syphilis.htm "Syphilis fact sheet" from the Center for Disease Control] | | *[http://www.cdc.gov/std/Syphilis/STDFact-Syphilis.htm "Syphilis fact sheet" from the Center for Disease Control] |
| *[http://www.nobel.se/medicine/laureates/1927/wagner-jauregg-lecture.html The treatment of dementia paralytica by malaria inoculation (A Nobel Prize lecture, December 13, 1927)]
| |
| *[http://www.niaid.nih.gov/factsheets/stdsyph.htm National Institute of Allergy and Infectious Diseases Factsheet]
| |
| *[http://uk.reuters.com/article/oddlyEnoughNews/idUKN1443055520080115 New study blames Columbus for syphilis spread from Reuters Jan 15, 2008]
| |
|
| |
| ==References==
| |
| {{reflist|2}}
| |
|
| |
|
| {{Diseases of the skin and appendages by morphology}} | | {{Diseases of the skin and appendages by morphology}} |
| Line 68: |
Line 50: |
| [[Category:Disease]] | | [[Category:Disease]] |
| [[Category:Gynecology]] | | [[Category:Gynecology]] |
| [[Category:Infectious disease]]
| |
|
| |
|
| [[Category:Bacterial diseases]] | | [[Category:Bacterial diseases]] |
| [[Category:Sexually transmitted diseases]] | | [[Category:Sexually transmitted diseases]] |